HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 204 filers reported holding HERON THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 2.25 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16 | -100.0% | 15,629 | -77.0% | 0.00% | -87.5% |
| Q2 2022 | $189,000 | -24.1% | 67,900 | +55.8% | 0.02% | -11.1% |
| Q1 2022 | $249,000 | +49.1% | 43,569 | +138.0% | 0.02% | +5.9% |
| Q4 2021 | $167,000 | -61.8% | 18,306 | -11.4% | 0.02% | -63.8% |
| Q4 2020 | $437,000 | -24.1% | 20,667 | -47.2% | 0.05% | -29.9% |
| Q2 2020 | $576,000 | +40.5% | 39,131 | +124.1% | 0.07% | +67.5% |
| Q4 2019 | $410,000 | -52.8% | 17,460 | -36.4% | 0.04% | -24.5% |
| Q3 2018 | $869,000 | +133.6% | 27,454 | +186.5% | 0.05% | +231.2% |
| Q2 2018 | $372,000 | +40.9% | 9,581 | +0.1% | 0.02% | +14.3% |
| Q1 2018 | $264,000 | -72.5% | 9,574 | -82.0% | 0.01% | -72.5% |
| Q4 2017 | $961,000 | +88.4% | 53,089 | +68.0% | 0.05% | +104.0% |
| Q3 2017 | $510,000 | – | 31,594 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |